Frequency
Latest
JNJ
Headlines
Endo will acquire Indevus for $370 million, or $4.50 per share.
5:16PM 01/05/09
To Marek Fuchs stomps on a Financial Times headline hyping a Pfizer merger and the article, which hypes industry consolidation.
01:46PM 01/05/09
These stocks, including American Financial, recently raised their dividends.
12:58PM 01/05/09
Same-store sales were up 4.9%, fueling the good month in the face of general economic weakness.
11:36AM 01/05/09
Catch up on his thinking on the hottest topics of the past week.
9:32AM 01/03/09
Fortunately, we have the right people in charge, so 2009 looks a lot brighter.
12:49PM 12/31/08
Bayer is alleging Abbott infringed on a patent with its autoimmune treatment, according to published reports Monday.
4:18PM 12/30/08
Take a cue from these 13 killer campaigns -- and five flops.
10:34AM 12/30/08
Johnson & Johnson says Omrix shareholders tendered about 97.8% of shares.
2:59PM 12/27/08
Stephanie Link, director of research for Jim Cramer's Action Alerts PLUS portfolio, discusses which China plays are on Cramer's radar.
08:58AM 12/27/08
Understanding the Market
Our Experts' Take at RealMoney for Johnson & Johnson
The Israeli defense contractor serves more than just the Israel Defense Forces.
3:44PM 01/05/09
The decline today is a big opportunity for these stocks.
3:32PM 01/05/09
More Experts' Takes on JNJ
More popular tickers are indicated by scale.
